Value addition by subspecialty trained radiologists in multidisciplinary tumor boards for pancreatic adenocarcinoma: a systematic review and meta-analysis.
메타분석
1/5 보강
PICO 자동 추출 (휴리스틱, conf 2/4)
유사 논문P · Population 대상 환자/모집단
067 patients, met inclusion criteria in a pool of 13,043 studies.
I · Intervention 중재 / 시술
추출되지 않음
C · Comparison 대조 / 비교
추출되지 않음
O · Outcome 결과 / 결론
[CLINICAL RELEVANCE/APPLICATION] This work highlights the ongoing involvement of subspecialty trained radiologists in the multidisciplinary team for PDAC, and it significantly influences clinical decisions. Applicability concerns exist due to a potential lack of resources for robust MDT initiatives outside of tertiary centers.
[OBJECTIVE] To perform a systematic review assessing the role of subspecialty radiologist in a multidisciplinary team (MDT) focused on pancreatic adenocarcinoma (PDAC) and the impact on patient outcom
- 95% CI 0.50-0.56
- 연구 설계 systematic review
APA
Caulfield A, Nanda B, et al. (2026). Value addition by subspecialty trained radiologists in multidisciplinary tumor boards for pancreatic adenocarcinoma: a systematic review and meta-analysis.. La Radiologia medica, 131(2), 190-200. https://doi.org/10.1007/s11547-025-02139-z
MLA
Caulfield A, et al.. "Value addition by subspecialty trained radiologists in multidisciplinary tumor boards for pancreatic adenocarcinoma: a systematic review and meta-analysis.." La Radiologia medica, vol. 131, no. 2, 2026, pp. 190-200.
PMID
41166033 ↗
Abstract 한글 요약
[OBJECTIVE] To perform a systematic review assessing the role of subspecialty radiologist in a multidisciplinary team (MDT) focused on pancreatic adenocarcinoma (PDAC) and the impact on patient outcomes.
[METHODS AND MATERIALS] Ovid MEDLINE, Ovid Embase, Cochrane Database of Systematic Reviews (Ovid), Cochrane Central Register of Controlled Trials (Ovid), and Web of Science searched until August 31, 2023, for studies including radiology review in PDAC MDT. Data extraction, risk of bias, and applicability assessment were performed by two authors. Random-effects meta-analysis was performed.
[RESULTS] Ten studies (four retrospective, six prospective, and four multi-center vs. six single center), including 2,067 patients, met inclusion criteria in a pool of 13,043 studies. Three studies including 977 patients demonstrated succinct changes in patient management (average estimate 0.53 (95% CI 0.50-0.56)) after a radiology review at the MDT. A random-effects meta-analysis of these studies show that approximately 44% of patients had their treatment plans changed after a meeting at the MDT that included a subspecialty trained radiologist, but there is a large range of uncertainty (18%-74%) due to differences in the studies' groups, what they considered a "change" and local practices. Two studies highlighted an important nuance: while MDT input is valuable, the interpretations can vary between teams or even within the same team over time, reflecting the complex nature of PDAC. None of the studies showed a statistically significant survival advantage solely from MDT involvement, likely because overall survival depends on many downstream factors.
[CONCLUSIONS] The presence of radiology review in the setting of multidisciplinary team meetings provides crucial information, leading to management changes. Future studies could explore advanced imaging modalities such as PET-MRI and establish the impact of intra/interobserver variability within the multidisciplinary team.
[CLINICAL RELEVANCE/APPLICATION] This work highlights the ongoing involvement of subspecialty trained radiologists in the multidisciplinary team for PDAC, and it significantly influences clinical decisions. Applicability concerns exist due to a potential lack of resources for robust MDT initiatives outside of tertiary centers.
[METHODS AND MATERIALS] Ovid MEDLINE, Ovid Embase, Cochrane Database of Systematic Reviews (Ovid), Cochrane Central Register of Controlled Trials (Ovid), and Web of Science searched until August 31, 2023, for studies including radiology review in PDAC MDT. Data extraction, risk of bias, and applicability assessment were performed by two authors. Random-effects meta-analysis was performed.
[RESULTS] Ten studies (four retrospective, six prospective, and four multi-center vs. six single center), including 2,067 patients, met inclusion criteria in a pool of 13,043 studies. Three studies including 977 patients demonstrated succinct changes in patient management (average estimate 0.53 (95% CI 0.50-0.56)) after a radiology review at the MDT. A random-effects meta-analysis of these studies show that approximately 44% of patients had their treatment plans changed after a meeting at the MDT that included a subspecialty trained radiologist, but there is a large range of uncertainty (18%-74%) due to differences in the studies' groups, what they considered a "change" and local practices. Two studies highlighted an important nuance: while MDT input is valuable, the interpretations can vary between teams or even within the same team over time, reflecting the complex nature of PDAC. None of the studies showed a statistically significant survival advantage solely from MDT involvement, likely because overall survival depends on many downstream factors.
[CONCLUSIONS] The presence of radiology review in the setting of multidisciplinary team meetings provides crucial information, leading to management changes. Future studies could explore advanced imaging modalities such as PET-MRI and establish the impact of intra/interobserver variability within the multidisciplinary team.
[CLINICAL RELEVANCE/APPLICATION] This work highlights the ongoing involvement of subspecialty trained radiologists in the multidisciplinary team for PDAC, and it significantly influences clinical decisions. Applicability concerns exist due to a potential lack of resources for robust MDT initiatives outside of tertiary centers.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- A Phase I Study of Hydroxychloroquine and Suba-Itraconazole in Men with Biochemical Relapse of Prostate Cancer (HITMAN-PC): Dose Escalation Results.
- Self-management of male urinary symptoms: qualitative findings from a primary care trial.
- Clinical and Liquid Biomarkers of 20-Year Prostate Cancer Risk in Men Aged 45 to 70 Years.
- Diagnostic accuracy of Ga-PSMA PET/CT versus multiparametric MRI for preoperative pelvic invasion in the patients with prostate cancer.
- Clinical Presentation and Outcomes of Patients Undergoing Surgery for Thyroid Cancer.
- Association of patient health education with the postoperative health related quality of life in low- intermediate recurrence risk differentiated thyroid cancer patients.